Trial Profile
Phase II trial of LY 2624803 in patients with mild to moderate transient insomnia.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Dec 2009
Price :
$35
*
At a glance
- Drugs LY 2624803 (Primary)
- Indications Insomnia
- Focus Therapeutic Use
- Sponsors Hypnion
- 18 Dec 2007 New trial record.